SMTL ID : 7n6r.1

Structure of nevanimibe bound human ACAT2

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

homo-tetramer

Ligands

4 x ROV: nevanimibe(Non-covalent)

ROV.1: 13 residues within 4Å: Chain A: F.242, I.362, F.366, Y.398, Y.399, W.402, N.403, V.406, S.438, H.442, F.446, Q.496 Ligands: OLA.4 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:F.242, A:I.362, A:F.366, A:Y.398, A:Y.399, A:W.402, A:N.403, A:V.406 Hydrogen bonds: A:N.403, A:H.442, A:H.442 ROV.5: 13 residues within 4Å: Chain B: F.242, I.362, F.366, Y.398, Y.399, W.402, N.403, V.406, S.438, H.442, F.446, Q.496 Ligands: OLA.8 11 PLIP interactions: 11 interactions with chain B Hydrophobic interactions: B:F.242, B:I.362, B:F.366, B:Y.398, B:Y.399, B:W.402, B:N.403, B:V.406 Hydrogen bonds: B:N.403, B:H.442, B:H.442 ROV.9: 13 residues within 4Å: Chain C: F.242, I.362, F.366, Y.398, Y.399, W.402, N.403, V.406, S.438, H.442, F.446, Q.496 Ligands: OLA.12 11 PLIP interactions: 11 interactions with chain C Hydrophobic interactions: C:F.242, C:I.362, C:F.366, C:Y.398, C:Y.399, C:W.402, C:N.403, C:V.406 Hydrogen bonds: C:N.403, C:H.442, C:H.442 ROV.13: 13 residues within 4Å: Chain D: F.242, I.362, F.366, Y.398, Y.399, W.402, N.403, V.406, S.438, H.442, F.446, Q.496 Ligands: OLA.16 11 PLIP interactions: 11 interactions with chain D Hydrophobic interactions: D:F.242, D:I.362, D:F.366, D:Y.398, D:Y.399, D:W.402, D:N.403, D:V.406 Hydrogen bonds: D:N.403, D:H.442, D:H.442

8 x CLR: CHOLESTEROL(Non-covalent)

CLR.2: 13 residues within 4Å: Chain A: F.168, C.238, V.239, F.242, E.243, R.246, V.316, A.319, C.320, L.323, F.366, W.370 Ligands: OLA.4 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:F.168, A:V.239, A:F.242, A:F.242, A:V.316, A:A.319, A:L.323 CLR.3: 11 residues within 4Å: Chain A: F.128, I.131, Y.132, F.135, I.136, L.360, F.364, W.390 Chain B: H.127, T.130, I.131 16 PLIP interactions: 14 interactions with chain A, 2 interactions with chain B Hydrophobic interactions: A:F.128, A:I.131, A:Y.132, A:F.135, A:F.135, A:F.135, A:I.136, A:L.360, A:L.360, A:F.364, A:F.364, A:F.364, A:F.364, A:W.390, B:I.131 Hydrogen bonds: B:H.127 CLR.6: 13 residues within 4Å: Chain B: F.168, C.238, V.239, F.242, E.243, R.246, V.316, A.319, C.320, L.323, F.366, W.370 Ligands: OLA.8 7 PLIP interactions: 7 interactions with chain B Hydrophobic interactions: B:F.168, B:V.239, B:F.242, B:F.242, B:V.316, B:A.319, B:W.370 CLR.7: 12 residues within 4Å: Chain A: H.127, T.130, I.131 Chain B: F.128, I.131, Y.132, F.135, I.136, C.315, L.360, F.364, W.390 16 PLIP interactions: 14 interactions with chain B, 2 interactions with chain A Hydrophobic interactions: B:F.128, B:I.131, B:Y.132, B:F.135, B:F.135, B:F.135, B:I.136, B:L.360, B:L.360, B:F.364, B:F.364, B:F.364, B:F.364, B:W.390, A:I.131 Hydrogen bonds: A:H.127 CLR.10: 13 residues within 4Å: Chain C: F.168, C.238, V.239, F.242, E.243, R.246, V.316, A.319, C.320, L.323, F.366, W.370 Ligands: OLA.12 7 PLIP interactions: 7 interactions with chain C Hydrophobic interactions: C:F.168, C:V.239, C:F.242, C:F.242, C:V.316, C:A.319, C:L.323 CLR.11: 11 residues within 4Å: Chain C: F.128, I.131, Y.132, F.135, I.136, L.360, F.364, W.390 Chain D: H.127, T.130, I.131 17 PLIP interactions: 3 interactions with chain D, 14 interactions with chain C Hydrophobic interactions: D:I.131, C:F.128, C:I.131, C:Y.132, C:F.135, C:F.135, C:F.135, C:I.136, C:L.360, C:L.360, C:F.364, C:F.364, C:F.364, C:F.364, C:W.390 Hydrogen bonds: D:H.127, D:I.131 CLR.14: 13 residues within 4Å: Chain D: F.168, C.238, V.239, F.242, E.243, R.246, V.316, A.319, C.320, L.323, F.366, W.370 Ligands: OLA.16 8 PLIP interactions: 8 interactions with chain D Hydrophobic interactions: D:F.168, D:V.239, D:F.242, D:F.242, D:V.316, D:A.319, D:L.323, D:W.370 CLR.15: 12 residues within 4Å: Chain C: H.127, T.130, I.131 Chain D: F.128, I.131, Y.132, F.135, I.136, C.315, L.360, F.364, W.390 17 PLIP interactions: 14 interactions with chain D, 3 interactions with chain C Hydrophobic interactions: D:F.128, D:I.131, D:Y.132, D:F.135, D:F.135, D:F.135, D:I.136, D:L.360, D:L.360, D:F.364, D:F.364, D:F.364, D:F.364, D:W.390, C:I.131 Hydrogen bonds: C:H.127, C:I.131

4 x OLA: OLEIC ACID(Non-covalent)

OLA.4: 18 residues within 4Å: Chain A: W.178, E.243, R.246, M.249, K.250, F.284, C.285, P.286, L.288, F.366, W.370, L.371, F.374, V.406, H.442, I.445 Ligands: ROV.1, CLR.2 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:R.246, A:L.288, A:F.366, A:W.370, A:L.371, A:F.374, A:F.374, A:V.406, A:I.445 Salt bridges: A:R.246 OLA.8: 16 residues within 4Å: Chain B: W.178, R.246, M.249, K.250, F.284, P.286, L.288, F.366, W.370, L.371, F.374, V.406, H.442, I.445 Ligands: ROV.5, CLR.6 10 PLIP interactions: 10 interactions with chain B Hydrophobic interactions: B:R.246, B:L.288, B:F.366, B:W.370, B:L.371, B:F.374, B:F.374, B:V.406, B:I.445 Salt bridges: B:R.246 OLA.12: 17 residues within 4Å: Chain C: W.178, R.246, M.249, K.250, F.284, C.285, P.286, L.288, F.366, W.370, L.371, F.374, V.406, H.442, I.445 Ligands: ROV.9, CLR.10 10 PLIP interactions: 10 interactions with chain C Hydrophobic interactions: C:R.246, C:L.288, C:F.366, C:W.370, C:L.371, C:F.374, C:F.374, C:V.406, C:I.445 Salt bridges: C:R.246 OLA.16: 16 residues within 4Å: Chain D: W.178, R.246, M.249, K.250, F.284, P.286, L.288, F.366, W.370, L.371, F.374, V.406, H.442, I.445 Ligands: ROV.13, CLR.14 10 PLIP interactions: 10 interactions with chain D Hydrophobic interactions: D:R.246, D:L.288, D:F.366, D:W.370, D:L.371, D:F.374, D:F.374, D:V.406, D:I.445 Salt bridges: D:R.246

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Li, X. et al., Structure of nevanimibe bound human ACAT2. To Be Published

Release Date

2021-09-15

Peptides

Sterol O-acyltransferase 2: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Sterol O-acyltransferase 2

Related Entries With Identical Sequence